Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Update

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 877 shares, a growth of 92.3% from the July 15th total of 456 shares. Based on an average trading volume of 1,618 shares, the short-interest ratio is presently 0.5 days. Approximately 0.3% of the shares of the company are sold short.

Innovator IBD Breakout Opportunities ETF Price Performance

Shares of NYSEARCA BOUT traded down $0.02 during mid-day trading on Friday, reaching $44.70. The company’s stock had a trading volume of 1,541 shares, compared to its average volume of 3,891. Innovator IBD Breakout Opportunities ETF has a 52 week low of $35.05 and a 52 week high of $49.41. The stock has a fifty day moving average of $46.85 and a two-hundred day moving average of $43.74. The firm has a market capitalization of $15.65 million, a PE ratio of 28.69 and a beta of 1.04.

Hedge Funds Weigh In On Innovator IBD Breakout Opportunities ETF

Large investors have recently made changes to their positions in the company. Comprehensive Wealth Management LLC grew its holdings in shares of Innovator IBD Breakout Opportunities ETF by 122.0% in the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after purchasing an additional 12,859 shares during the last quarter. Susquehanna International Group LLP boosted its stake in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after purchasing an additional 7,817 shares in the last quarter. Finally, Osaic Holdings Inc. boosted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after buying an additional 597 shares in the last quarter.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.